Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -1.4 Million USD | 73.27% |
| 2021 | -5.27 Million USD | 69.34% |
| 2020 | -17.19 Million USD | -5.29% |
| 2019 | -16.33 Million USD | -23.49% |
| 2018 | -13.22 Million USD | 17.74% |
| 2017 | -16.07 Million USD | 50.37% |
| 2016 | -32.39 Million USD | 26.77% |
| 2015 | -44.23 Million USD | -713.41% |
| 2014 | -5.43 Million USD | -51.56% |
| 2013 | -3.58 Million USD | 12.38% |
| 2012 | -4.09 Million USD | -62.82% |
| 2011 | -2.51 Million USD | -34.71% |
| 2010 | -1.86 Million USD | 89.47% |
| 2009 | -17.72 Million USD | -123.23% |
| 2008 | -7.94 Million USD | -597.93% |
| 2007 | 1.59 Million USD | 111.93% |
| 2006 | -13.37 Million USD | -51.32% |
| 2005 | -8.83 Million USD | 34.63% |
| 2004 | -13.52 Million USD | -88.33% |
| 2003 | -7.18 Million USD | 43.09% |
| 2002 | -12.61 Million USD | -53.21% |
| 2001 | -8.23 Million USD | 4.11% |
| 2000 | -8.58 Million USD | 33.59% |
| 1999 | -12.93 Million USD | 16.57% |
| 1998 | -15.5 Million USD | -134.85% |
| 1997 | -6.6 Million USD | -306.25% |
| 1996 | 3.2 Million USD | -50.77% |
| 1995 | 6.5 Million USD | 400.0% |
| 1994 | 1.3 Million USD | 186.67% |
| 1993 | -1.5 Million USD | -354.24% |
| 1992 | 590 Thousand USD | -55.3% |
| 1991 | 1.32 Million USD | 118.46% |
| 1990 | -7.15 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | 752.04 Thousand USD | -46.18% |
| 2023 Q2 | 2.09 Million USD | 178.84% |
| 2023 Q3 | -600.97 Thousand USD | -128.66% |
| 2022 FY | -1.4 Million USD | 73.27% |
| 2022 Q3 | -924.81 Thousand USD | -2587.39% |
| 2022 Q4 | 1.39 Million USD | 251.1% |
| 2022 Q2 | 37.18 Thousand USD | 101.94% |
| 2022 Q1 | -1.91 Million USD | -41897.44% |
| 2021 Q4 | -4570.00 USD | 99.81% |
| 2021 FY | -5.27 Million USD | 69.34% |
| 2021 Q3 | -2.35 Million USD | -57.82% |
| 2021 Q1 | -5.22 Million USD | 11.64% |
| 2021 Q2 | -1.49 Million USD | 71.47% |
| 2020 FY | -17.19 Million USD | -5.29% |
| 2020 Q1 | -5.75 Million USD | -41.82% |
| 2020 Q2 | -3.31 Million USD | 42.4% |
| 2020 Q3 | -4.18 Million USD | -26.26% |
| 2020 Q4 | -5.91 Million USD | -41.31% |
| 2019 Q1 | -4.47 Million USD | -3.95% |
| 2019 Q2 | -5.09 Million USD | -13.92% |
| 2019 Q3 | -2.7 Million USD | 46.92% |
| 2019 Q4 | -4.05 Million USD | -49.92% |
| 2019 FY | -16.33 Million USD | -23.49% |
| 2018 FY | -13.22 Million USD | 17.74% |
| 2018 Q1 | -3.71 Million USD | -55.94% |
| 2018 Q4 | -4.3 Million USD | -52.85% |
| 2018 Q3 | -2.81 Million USD | -17.64% |
| 2018 Q2 | -2.39 Million USD | 35.52% |
| 2017 Q2 | -4.25 Million USD | 7.96% |
| 2017 Q3 | -5.16 Million USD | -21.28% |
| 2017 Q4 | -2.38 Million USD | 53.9% |
| 2017 Q1 | -4.62 Million USD | 41.9% |
| 2017 FY | -16.07 Million USD | 50.37% |
| 2016 FY | -32.39 Million USD | 26.77% |
| 2016 Q1 | -6.76 Million USD | 65.08% |
| 2016 Q2 | -5.09 Million USD | 24.75% |
| 2016 Q3 | -12.57 Million USD | -147.08% |
| 2016 Q4 | -7.96 Million USD | 36.69% |
| 2015 Q2 | -1.35 Million USD | 32.08% |
| 2015 Q3 | -964 Thousand USD | 28.65% |
| 2015 FY | -44.23 Million USD | -713.41% |
| 2015 Q1 | -1.98 Million USD | -74.47% |
| 2015 Q4 | -19.37 Million USD | -1909.59% |
| 2014 Q2 | -1.27 Million USD | -28.8% |
| 2014 Q1 | -986 Thousand USD | 3.43% |
| 2014 Q4 | -1.14 Million USD | -9.72% |
| 2014 Q3 | -1.03 Million USD | 18.19% |
| 2014 FY | -5.43 Million USD | -51.56% |
| 2013 Q4 | -1.02 Million USD | -17.09% |
| 2013 Q3 | -872 Thousand USD | -22.99% |
| 2013 Q2 | -709 Thousand USD | 16.39% |
| 2013 Q1 | -848 Thousand USD | 33.18% |
| 2013 FY | -3.58 Million USD | 12.38% |
| 2012 Q1 | -717 Thousand USD | -81.98% |
| 2012 FY | -4.09 Million USD | -62.82% |
| 2012 Q2 | -687 Thousand USD | 4.18% |
| 2012 Q3 | -1.29 Million USD | -88.06% |
| 2012 Q4 | -1.26 Million USD | 1.78% |
| 2011 Q4 | -394 Thousand USD | 28.23% |
| 2011 FY | -2.51 Million USD | -34.71% |
| 2011 Q3 | -549 Thousand USD | 35.71% |
| 2011 Q2 | -854 Thousand USD | -151.6% |
| 2011 Q1 | 1.65 Million USD | 389.34% |
| 2010 Q1 | -4.37 Million USD | 48.72% |
| 2010 Q2 | -2.56 Million USD | 41.47% |
| 2010 Q3 | -388 Thousand USD | 84.86% |
| 2010 Q4 | -572 Thousand USD | -47.42% |
| 2010 FY | -1.86 Million USD | 89.47% |
| 2009 Q1 | -3.11 Million USD | -119.86% |
| 2009 Q4 | -8.53 Million USD | -373.64% |
| 2009 FY | -17.72 Million USD | -123.23% |
| 2009 Q2 | -3.01 Million USD | 3.18% |
| 2009 Q3 | -1.8 Million USD | 40.17% |
| 2008 Q1 | 756 Thousand USD | -56.78% |
| 2008 FY | -7.94 Million USD | -597.93% |
| 2008 Q3 | -2.43 Million USD | -147.86% |
| 2008 Q4 | -1.41 Million USD | 41.87% |
| 2008 Q2 | -982 Thousand USD | -229.89% |
| 2007 Q2 | -1.36 Million USD | 31.73% |
| 2007 Q1 | -2 Million USD | 68.81% |
| 2007 FY | 1.59 Million USD | 111.93% |
| 2007 Q4 | 1.74 Million USD | 283.55% |
| 2007 Q3 | 456 Thousand USD | 133.38% |
| 2006 Q2 | -1.84 Million USD | 21.57% |
| 2006 Q1 | -2.35 Million USD | -99.24% |
| 2006 FY | -13.37 Million USD | -51.32% |
| 2006 Q4 | -6.41 Million USD | -105.94% |
| 2006 Q3 | -3.11 Million USD | -68.93% |
| 2005 Q2 | -2.38 Million USD | 38.08% |
| 2005 FY | -8.83 Million USD | 34.63% |
| 2005 Q1 | -3.85 Million USD | -31.29% |
| 2005 Q4 | -1.18 Million USD | 59.63% |
| 2005 Q3 | -2.92 Million USD | -22.56% |
| 2004 Q2 | -4.23 Million USD | -6922.58% |
| 2004 Q3 | -2.5 Million USD | 40.76% |
| 2004 FY | -13.52 Million USD | -88.33% |
| 2004 Q4 | -2.93 Million USD | -17.08% |
| 2004 Q1 | 62 Thousand USD | 101.34% |
| 2003 Q4 | -4.61 Million USD | -250.46% |
| 2003 Q2 | -1.31 Million USD | 28.7% |
| 2003 Q1 | -1.84 Million USD | 44.5% |
| 2003 FY | -7.18 Million USD | 43.09% |
| 2003 Q3 | -1.31 Million USD | -0.15% |
| 2002 Q4 | -3.32 Million USD | 28.86% |
| 2002 FY | -12.61 Million USD | -53.21% |
| 2002 Q3 | -4.66 Million USD | -67.61% |
| 2002 Q2 | -2.78 Million USD | -127.35% |
| 2002 Q1 | -1.22 Million USD | 45.8% |
| 2001 Q2 | -2.37 Million USD | 55.23% |
| 2001 Q4 | -2.26 Million USD | 4.8% |
| 2001 Q3 | -2.37 Million USD | 0.17% |
| 2001 Q1 | -5.31 Million USD | -408.23% |
| 2001 FY | -8.23 Million USD | 4.11% |
| 2000 Q3 | 131 Thousand USD | 105.54% |
| 2000 FY | -8.58 Million USD | 33.59% |
| 2000 Q4 | -1.04 Million USD | -897.71% |
| 2000 Q1 | -2.03 Million USD | 32.27% |
| 2000 Q2 | -2.36 Million USD | -16.29% |
| 1999 Q1 | -4.8 Million USD | -26.32% |
| 1999 FY | -12.93 Million USD | 16.57% |
| 1999 Q4 | -3 Million USD | 26.83% |
| 1999 Q3 | -4.1 Million USD | -5.13% |
| 1999 Q2 | -3.9 Million USD | 18.75% |
| 1998 Q1 | -2.2 Million USD | -57.14% |
| 1998 Q4 | -3.8 Million USD | -15.15% |
| 1998 Q3 | -3.3 Million USD | 5.71% |
| 1998 Q2 | -3.5 Million USD | -59.09% |
| 1998 FY | -15.5 Million USD | -134.85% |
| 1997 Q2 | -1.6 Million USD | -633.33% |
| 1997 Q3 | -1.3 Million USD | 18.75% |
| 1997 Q4 | -1.4 Million USD | -7.69% |
| 1997 FY | -6.6 Million USD | -306.25% |
| 1997 Q1 | 300 Thousand USD | -25.0% |
| 1996 FY | 3.2 Million USD | -50.77% |
| 1996 Q3 | 300 Thousand USD | -86.36% |
| 1996 Q4 | 400 Thousand USD | 33.33% |
| 1996 Q1 | 1.8 Million USD | 28.57% |
| 1996 Q2 | 2.2 Million USD | 22.22% |
| 1995 FY | 6.5 Million USD | 400.0% |
| 1995 Q4 | 1.4 Million USD | -90.21% |
| 1995 Q2 | 13.1 Million USD | 141.32% |
| 1995 Q3 | 14.3 Million USD | 9.16% |
| 1995 Q1 | -31.7 Million USD | -378.07% |
| 1994 FY | 1.3 Million USD | 186.67% |
| 1994 Q4 | 11.4 Million USD | -3.96% |
| 1994 Q3 | 11.87 Million USD | 18.7% |
| 1994 Q2 | 10 Million USD | 0.0% |
| 1993 FY | -1.5 Million USD | -354.24% |
| 1992 FY | 590 Thousand USD | -55.3% |
| 1991 FY | 1.32 Million USD | 118.46% |
| 1990 FY | -7.15 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -13.489% |
| Arrayit Corporation | -3.62 Million USD | 61.09% |
| Atlantic International Corp. | -5.73 Million USD | 75.412% |
| Biocept, Inc. | -31.98 Million USD | 95.593% |
| Bioqual, Inc. | -19.63 Thousand USD | -7077.584% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -82.549% |
| DermTech, Inc. | -103.73 Million USD | 98.641% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.057% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 93.233% |
| iMD Companies, Inc. | -175.44 Thousand USD | -703.4% |
| IDenta Corp. | -1499.00 USD | -93931.621% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 150.269% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 3743.148% |
| InVitro International | -25.33 Thousand USD | -5462.706% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 80.209% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -2325.547% |
| Medical Imaging Corp. | -819.48 Thousand USD | -72.003% |
| NovelStem International Corp. | -3.52 Million USD | 60.022% |
| Optigenex Inc. | 1.39 Million USD | 201.344% |
| PharmChem, Inc. | 973.14 Thousand USD | 244.843% |
| Proteome Sciences plc | -1.62 Million USD | 13.045% |
| Response Genetics, Inc | -21.37 Million USD | 93.406% |
| RushNet, Inc. | -684.7 Thousand USD | -105.86% |
| ScreenPro Security Inc. | -2.59 Million USD | 45.629% |
| Stella Diagnostics Inc. | -11.42 Million USD | 87.665% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 81.805% |
| Todos Medical Ltd. | -9.74 Million USD | 85.54% |